| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −11.0× | −1.8× | |
| Price / Book | 10.1× | 2.1× | |
| Price / Sales | 7.6× | 4.0× | |
| Price / Free cash flow | −11.5× | −1.6× | |
| EV / EBITDA | −14.1× | −1.1× | |
| Earnings yield | −9.1% | −14.1% | |
| Free cash flow yield | −8.7% | −9.6% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,268.37 | −2.93% | $1.19T | 59.6× | 77.8% | +21.1% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $263.17 | −1.66% | $633.53B | 24.0× | 32.9% | +39.5% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $285.72 | +0.19% | $504.9B | 119.3× | −129.2% | +23.3% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $417.78 | −1.69% | $375B | 31.6× | 12.8% | +16.3% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.93 | −1.57% | $357.55B | 19.9× | 34.7% | +68.0% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.19 | −3.89% | $270.64B | 20.0× | 30.5% | +19.0% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $170.97 | −0.93% | $265.16B | 26.1× | 21.1% | +3.3% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $669.62 | −1.02% | $247.59B | 37.1× | 12.6% | +21.2% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $440.50 | −1.52% | $238.15B | 31.4× | 89.1% | +48.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $156.82 | −0.24% | $194.45B | 22.9× | 37.5% | +26.7% |
